Literature DB >> 638334

Potentiation of monoamine responses of denervated cells by a noradrenaline uptake inhibitor (viloxazine) [proceedings].

R S Jones, M H Roberts.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 638334      PMCID： PMC1668201     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  7 in total

1.  The effect of tricyclic antidepressants on cholinergic responses of single cortical neurones.

Authors:  P Bevan; C M Bradshaw; E Szabadi
Journal:  Br J Pharmacol       Date:  1975-01       Impact factor: 8.739

2.  Accumulation of tritiated 5-hydroxytryptamine in brain slices.

Authors:  S B Ross; A L Renyl
Journal:  Life Sci       Date:  1967-07-01       Impact factor: 5.037

3.  Effects of viloxazine on cortical neurone responses to monoamines and acetylcholine [proceedings].

Authors:  R S Jones; M H Roberts
Journal:  Br J Pharmacol       Date:  1977-03       Impact factor: 8.739

4.  Catecholamine uptake by synaptosomes in homogenates of rat brain: stereospecificity in different areas.

Authors:  J T Coyle; S H Snyder
Journal:  J Pharmacol Exp Ther       Date:  1969-12       Impact factor: 4.030

5.  Effects of imipramine and desipramine on responses of single cortical neurones to noradrenaline and 5-hydroxytryptamine.

Authors:  C M Bradshaw; M H Roberts; E Szabadi
Journal:  Br J Pharmacol       Date:  1974-11       Impact factor: 8.739

6.  Effects of viloxazine, an antidepressant agent, on biogenic amine uptake mechanisms and related activities.

Authors:  W Lippman; T A Pugsley
Journal:  Can J Physiol Pharmacol       Date:  1976-08       Impact factor: 2.273

7.  Effects of iprindole on responses of single cortical and caudate neurones to monoamines and acetylcholine.

Authors:  P Bevan; C M Bradshaw; E Szabadi
Journal:  Br J Pharmacol       Date:  1975-09       Impact factor: 8.739
  7 in total
  2 in total

1.  New Insights into the Mechanism of Action of Viloxazine: Serotonin and Norepinephrine Modulating Properties.

Authors:  Chungping Yu; Jennie Garcia-Olivares; Shawn Candler; Stefan Schwabe; Vladimir Maletic
Journal:  J Exp Pharmacol       Date:  2020-08-25

Review 2.  Viloxazine in the Management of CNS Disorders: A Historical Overview and Current Status.

Authors:  Robert L Findling; Shawn A Candler; Azmi F Nasser; Stefan Schwabe; Chungping Yu; Jennie Garcia-Olivares; Welton O'Neal; Jeffrey H Newcorn
Journal:  CNS Drugs       Date:  2021-05-18       Impact factor: 5.749
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.